Ibions’ Post

🆕 September means the start of a new school year! And this one has started with important news from the #BioRegionCatalonia, from basic research to clinical applications and international business expansion. Here you have some picks of the month: 🔺 Kick off of the seventh edition of #CRAASHBarcelona, the acceleration program promoted by #Biocat and Cimit (Boston) 🔺 #dHealthBcn enters the prototyping phase 🔺 Turning to startup investment: Kokuai closed a round of founding, ALLOX has received founding from @CDTI_innovacion and Asabys Partners and Lumiris Spectral Solutions has opened a crowdfunding round. 🔺 We've opened a call to have a spot in the ‘Catalonia Health Innovation Ecosystem Pavilion’ at 4YFN 🔺 AbilityPharma has boosted the efficacy of chemotherapy for endometrial cancer by over 40% 🔺 Researches and new scientific discoveries such as a study led by IRB Barcelona that has identified the five best biomarkers to predict response to immunotherapy in cancer and the 4D-Bioskin project with the participation of Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, Universitat de Barcelona and Reig Jofre among others. 🔺 Mollet University Hospital (FSM Fundació Sanitària Mollet) won the 2024 IHF Award for low carbon emissions in healthcare and Hospital Clínic de Barcelona and Universitat de Barcelona 🔺 Generalitat de Catalunya announced the creation of a think tank to uphold the health's system's quality and sustainability. 🔺 In terms of big pharmaceutical corporations we have news from Venair , Reig Jofre and Ferrer. 🔺 Mateo Valero has been awarded Barcelonaian of the Year, and we are also celebrating the winners of the trifermed Awards. We tell you about all of them on our monthly wrap up 👇 🔗 https://lnkd.in/dYdhV-Ei Would you prefer to receive this monthly content by e-mail, you can subscribe to the BioRegion Bites newsletter: 📲 https://lnkd.in/eg43Bxhh

Adopter categories When innovation is introduced into any social system, there are very few people to immediately accept and put them into use and some farmers take very long time to accept and use it. All farmers do no adopt at the same time and differ in their approaches. Apart from other factors, one of the concepts that brings variation among farmers is innovativeness. Some innovations are readily accepted by farmers, while some others are not readily accepted by farmers, even after a long period of time and some innovations are not at all accepted by the farmers. According to Rogers (1971), the farmers based on their innovativeness can be classified as 1) Innovators (Venturesome). 2) Early adopters (Respectable). 3) Early majority (Deliberate). 4) Late majority (Skeptical). 5) Laggards (Traditional). All members of a social system do not adopt an innovation at the same time. Rather, they adopt in an ordered time sequence, and they can be categorized as early adopters or late adopters depending on when they first use a new idea. It is highly useful for extension workers in a technology transfer programme to identify individuals who are likely to adopt innovations early and those who are likely to lag behind

Adopter categories When innovation is introduced into any social system, there are very few people to immediately accept and put them into use and some farmers take very long time to accept and use it. All farmers do no adopt at the same time and differ in their approaches. Apart from other factors, one of the concepts that brings variation among farmers is innovativeness. Some innovations are readily accepted by farmers, while some others are not readily accepted by farmers, even after a long period of time and some innovations are not at all accepted by the farmers. According to Rogers (1971), the farmers based on their innovativeness can be classified as 1) Innovators (Venturesome). 2) Early adopters (Respectable). 3) Early majority (Deliberate). 4) Late majority (Skeptical). 5) Laggards (Traditional). All members of a social system do not adopt an innovation at the same time. Rather, they adopt in an ordered time sequence, and they can be categorized as early adopters or late adopters depending on when they first use a new idea. It is highly useful for extension workers in a technology transfer programme to identify individuals who are likely to adopt innovations early and those who are likely to lag behind

🧬 Weekly Investment News in Biotech & Health 📰 💉 Metsera raises $215M in Series B funding, led by Wellington Management and Venrock, to develop its GLP-1 receptor agonist for obesity treatment, with total funding surpassing $500M. 🔬 Clair Scientific secures €1.6M from Export and Investment Fund of Denmark and Innovestor to advance its Z1 microscope, a compact, cloud-enabled imaging solution for life sciences. 🧠 Trace Neuroscience garners $101M led by Third Rock Ventures, with participation from Atlas Venture and RA Capital Management, to advance RNA-binding therapies for ALS. 🍃 Zymofix raises €2M from HTGF | High-Tech Gründerfonds and The Nest Family Office to scale microbial solutions from agricultural waste to enhance soil health. 🧩 Paloma Health secures £2M led by Triple Point to deliver faster autism assessments through NHS pathways and expand AI-enabled health services. ⚙️ Okami Medical gains $32.5M led by Vensana Capital to commercialize its catheter-based LOBO vascular occlusion system for arterial treatments. 💡 Quantune Technologies GmbH closes €13.5M from Point72 Ventures and Vsquared Ventures to develop non-invasive health monitoring wearables. 🌟 Alentis Therapeutics raises $181.4M in Series D funding led by OrbiMed, Novo Holdings, and JEITO to advance Claudin-1 ADCs for solid tumors. 🩺 AdipoPharma SAS gains funding from NEWTON BIOCAPITAL and others to begin Phase I trials of PATAS, a novel treatment for type 2 diabetes. 📈 mediaire raises €12M from LBO France and IBB Ventures to expand AI radiology solutions for MRI diagnostics across Europe. ⚕️ Serenity closes $5.5M in Series A funding led by Allegion to enhance its AI-powered Environmental Health & Safety software. 💓 Phlox Therapeutics secures €1.9M from ROM Utrecht Region and UHSF to develop RNA therapies targeting genetic heart diseases. 🦷 Biolux Technology raises €4.26M from redalpine and Revere Partners for light-accelerated orthodontics to reduce treatment times by up to 50%. 🏃 Coopah raises £1.5M from Redrice Ventures and Active Partners to scale its AI-powered running app and expand personalized training features. 🚀 ZAP Surgical Systems, Inc. secures $78M in Series E funding led by Qingdao Baheal Medical to commercialize its non-invasive robotic brain surgery platform. #Startups #Biotech #HealthTech #Innovation #VentureCapital

🧬 This week's Austin Bio & Health Roundup features nearly $200M in funding & new capital, M&A, more infrastructure coming, & hopefully an opening of the Texas Bio & Health IPO window🧬 💰 Funding Function Health has closed its Series A, securing $53M in total funding. Function’s platform offers 100+ tests for $499 per year, focusing on prevention and empowerment. The round was led by a16z Bio + Health and includes several celebrity investors. Congrats to Mark Hyman, MD, Pranitha Patil, Jonathan Swerdlin, Mike Nemke, Seth Weisfeld, and Dan Swerdlin. Sensi.AI raised a $31M Series B led by Insight Partners and Zeev Ventures to enhance its 24/7 monitoring technology for seniors and home care. Way to go Romi Gubes and the entire team! Ironspring Ventures raised $100M for their second fund, focusing on “manufacturing, construction, transportation, and energy.” Exciting times for Ty Findley, Adam Bridgman, Peter J. Holt, and the expanding Ironspring team! Now, why include this in a Bio & Health newsletter? I believe there will be a value migration from drugs, devices, and diagnostics to the bio innovation tech stack itself. One key area of that stack is biomanufacturing. As new modalities like cell and gene therapy rise, the challenge of scaling these therapies presents a significant opportunity for innovation. While as far as I know Ironspring hasn't invested in this subsector yet, I look forward to seeing what they do with Fund 2. 🤝 M&A and Partnerships Significo, a software development that builds healthcare apps and solutions, acquired Bunch, an AI leadership coach app. Congrats to Rick McCartney and team! 🚀Launches, Expansions, and Milestones BrainCheck, a cognitive assessment software platform, announced their adoption by the Physicians Hearing Network (PHN), bringing insights to 270 members across 12 states.  Keep up the momentum Kim Rodriguez and team! 🏗️ Infrastructure Texas State University is partnering with Concept Companies to build a life sciences incubator at their round rock campus. The incubator will have labs, offices, admin support, and collaboration spaces. The teams hope to complete construction by the end of 2025. DES Architects + Engineers opened a new office in Austin, aiming to bring their expertise to the city’s burgeoning life science market. Welcome Kevin D. Norman, Tracy Wong, and the rest of the DES team! 🚩 Texas Bio Triangle Fort Worth-based biopharma company Actuate Therapeutics, Inc. is preparing for an IPO, targeting a raise of about $50M. What’s Next? #AustinNext #LifeSciences #Healthcare #Biotechnology

From lab to marketplace?   This transition is challenging for start-ups, but Ireland’s universities and institutes of technology are fostering promising ventures. Here are nine research-backed Irish start-ups making waves:   🟢Amethyst Care Start Up Project: A Trinity College Dublin project developing an AI-powered voice assistant for people with mobility issues. Recently raised over €500,000 and aims to begin trials by January 2025. 🟢Carrick Therapeutics: An oncology-focused biopharma start-up at NovaUCD, developing therapies for cancer. Recently moved headquarters to Boston and raised $60m for clinical trials of a novel breast cancer treatment. 🟢Deciphex: Based at Dublin City University Alpha, this start-up offers an AI diagnostic platform for remote pathology. Recently partnered with Novartis to develop AI tools for drug discovery. 🟢Giyst: A Cork-based start-up creating an AI video summarization platform to efficiently repurpose content. Launched with the support of NovaUCD and CeADAR. 🟢HAON Life Science: Developing a novel cell therapy platform, with a focus on treating neonatal hypoxic ischemic encephalopathy (HIE). Finalist at the EIT Health European Wild Card competition. 🟢LaNua Medical: Based in NovaUCD, it developed a minimally invasive device for embolisation. Winner of the Enterprise Ireland Big Ideas Award and preparing for the Pegasus Startup World Cup. 🟢MYNDGARD - Helping Therapists gain better insights into Young People's Mental Health: Focused on youth mental health, this Trinity College Dublin spin-out is improving its offerings through clinical trials and raising funds for market expansion. 🟢NeuroBell: Specializes in AI-powered medical devices for newborns to detect seizures, reducing the risk of brain injuries. Raised €2.1m in January. 🟢seamlessCARE Ltd: Developing technology to enhance communication and support for people with disabilities. Raised €700,000 to roll out assistive tech like AI-powered Empathic for service providers.   These start-ups, born from academic research, are catching the eyes of investors and making significant strides in their respective fields. #startups #technology #ireland Silicon Republic 👈

Last Monday, we kick-started the #FuturizeU2024 cohort, marking a full-circle moment for me. This time last year, I was on the other side as a participant with my startup, Mari Test, in the inaugural FuturizeU incubator. Today, I'm part of the incredible team Futurize as the Incubation Program Manager, bringing the knowledge and insights I’ve gained to help guide the next generation of innovators. FuturizeU, launched by Futurize in partnership with AstraZeneca through the A.Catalyst Network, is focused on nurturing & launching African startups in healthcare and climate action founded by young people. This year’s cohort is truly remarkable, representing the diversity and potential of our continent with startups from Egypt (North Africa), South Africa, Kenya (East Africa), Rwanda (Central East Africa), and Nigeria (West Africa). 🚀 Meet the Startups: ACUBED: Aggregating diagnostic tests via mobile app/call center. Alpha Eye: AI-driven diagnostics for early vision impairment detection. Cardiac TEK: AI for real-time ECG interpretation and cardiovascular disease management. MedLab Diagnostics: AI-based cervical cancer diagnostic tool. PILL PALL: using AI to provide emergency health solution. Sadia Health: AI model for early liver cancer diagnosis. Tulivu.AI: AI device for early pregnancy complication detection. uMama: AI-powered, culturally relevant nutrition for mothers. WAD Pharma: Optimizing Africa’s pharmaceutical supply chain. Zoner Health: AI-powered diagnosis and medical records. Check Me Ltd: AI-driven breast cancer care. Allof Health: Secure health data documentation and sharing. Medicompanion: Smart pill dispenser with caregiver app. Conformity AI: AI-based automated radiotherapy planning. These startups are poised to make a significant impact on healthcare across Africa, and I can’t wait to see their growth over the next 12 weeks. Stay tuned to our social media channels, Futurize, for more updates on their journey. #FuturizeU2024 #AfricanInnovation #HealthcareStartup

📢 A Big Thank You from the Bioinnovation Team! 🌿💡 On behalf of the BioInnovation Greece founders Nikos Kyrpides , Georgios Pavlopoulos, Michalis Hadjithomas and Georgia Kokaraki PhD, PMP as well as the entire BIO3 organizing committee, we want to extend our heartfelt thanks to everyone who contributed and participated in making BIO3 Forum 2024 such an outstanding success! 🙌 With over 350 participants from 19 countries, 104 speakers, and 50+ biotech companies from the U.S., Europe, and Greece, your involvement made this event a true hub for collaboration between science, industry, and innovation. Special thanks to the Greek diaspora for joining us from across the globe. Together, we explored groundbreaking microbiome applications, innovative therapies, and biotech growth strategies. Key discussions spotlighted the challenges and opportunities for Greek startups in attracting international investors. The importance of the "One Health" global health strategy was emphasized, alongside dynamic talks, educational sessions, and investor-researcher collaborations. The forum concluded with key takeaways: • Fostering Collaborations: Closer cooperation between research centers, startups, and industry is essential for translating research into real-world applications. • Startup Support: Strengthening connections between Greek and international investors and biotech startups is crucial. Policies and funding tools must facilitate this. • Educational Programs: Providing educational opportunities in innovation, entrepreneurship, and funding is vital for progress. • Support Networks: Collaboration between researchers, entrepreneurs, and investors should be enhanced through organized platforms for knowledge sharing. • Biotech Development Strategy: Strengthening policies to attract foreign investments and innovation is key to Greece’s biotech growth. With the right steps, Greece can become a global hub for biotech innovation, improving health, well-being, and quality of life worldwide. 🌍🔬 Stay tuned for more updates, news, and future events! 🎉 TileDB, Kos Biotechnology Partners , John S. Latsis Public Benefit Foundation, International Probiotics Association, DeepLab, Intelligencia AI, Biomedcode, StArtBio- Molecular Allergy diagnostics & Biotechnology Services, Computational and Structural Biotech Journal, @akadimaikesekdoseis, Lifebit, Lab Supplies Scientific, The American College of Greece, Foundation for Research and Technology - Hellas (FORTH), @mikrobiokosmos , Orgenesis Inc., American Society for Microbiology, Komvos-Node, ARISTEiA, Endeavor Greece, @microbiometimes #BIO3 #Biotech #Innovation #BioInnovationGreece #OneHealth #Collaboration #Startups #greece #bio32024 #biotech #lifesciences

We’re thrilled to announce that 4baseCare has secured $6 million 💰 in Series A funding, led by Yali Capital and other investors. The funding will be used to enhance product offerings and scaling up operations for further expansion 🚀across India 🇮🇳  Commenting on the investment, Mathew Cyriac, Founding General Partner, Yali Capital said, “The genomics landscape in cancer care offers a tremendous opportunity to create impactful businesses while improving millions of lives. “ 4baseCare’s genomic tests have made a substantial impact across SouthEast Asia, impacting over 10,000 cancer patients. The company’s experienced founding team is supported by a notable Advisory Board with the very recent addition of Francis deSouza, a Silicon Valley tech 💻 veteran and former CEO of Illumina. Over the next few months, 4baseCare will set up genomics laboratories 🧪 in the Philippines, Nepal, and Dubai. Additionally, they will focus on building genomics 🧬 and digital health solutions, focusing on advanced data analytics, improved clinical insights, and data-driven treatment recommendations with further advancements in :- 🔎 Early Detection and diagnosis of cancer. 🧬 Better identification of different types of cancer. 💊 Using targeted therapies to improve patient outcomes. It is great news that genomics is getting the recognition and importance it deserves and investments from stalwarts which will go a long way in transforming health outcomes for millions ! Read more at:- StartupStory- https://shorturl.at/O1daB VCcircle- https://shorturl.at/3pPFB Your Story- https://shorturl.at/fpZJr INC42- https://shorturl.at/ADdz7 Hitesh Goswami Kshitij Rishi Mount Judi Ventures Season Two Ventures Ganapathy Subramaniam IlluminagrowX ventures Merak Ventures Mathew Cyriac Lip-Bu Tan George Church Aditya Somani Suneel Regulla Mallika Guha #healthcare #oncology #investment #YaliCapital #4BaseCare #PrecisionOncology #funding #startup #SeriesA #fundraising #networking #HealthTech #HealthcareInnovation

Cicada Innovations is thrilled to shine a spotlight on the innovative startups that presented at our inaugural Annual Showcase. Held at the Cicada HealthTech Hub in Westmead, this event celebrated the groundbreaking achievements of our residents and the future of healthcare in Australia. Our resident startups stole the show, presenting their cutting-edge health solutions to a panel of investors and the wider audience. These seven innovative ventures showcased their potential to revolutionise healthcare:  Dr Jeremy K. from iiShield discussed how his innovative tech ‘the KidneyPJ’, is a single-use, thermoprotective device that prolongs transplant procedure time by preventing kidney warming, enhancing surgical conditions, and improving transplant outcomes. Meanwhile, James Reilly, from Latent Knowledge, outlined how their AI-driven research platform connects users with relevant literature, enhancing R&D outcomes through advanced natural language processing and visualisation techniques. Alison Williams, from Outcomes Nutrition Tummily, is making waves with an AI-driven tool for IBS management. Tummily offers personalised nutrition guidance and equips healthcare providers with tailored meal plans and actionable patient insights. Philip Crealy from High Fidelity Orthopaedics is driving Innovative orthopaedic solutions to provide advanced, patient-matched implants and precision instruments to improve outcomes, streamline procedures, and enable efficient, high-quality surgical care. Joanne Cooper,  from World Data Exchange, is creating a platform empowering individuals to control and securely share personal healthcare data, enabling consent-driven, transparent exchanges between users, providers, and organisations worldwide. Bruce Allan, from Triggar Media is creating immersive digital health solutions that leverage VR and AR to create tools for therapy, recovery, and patient engagement, transforming healthcare experiences. And finally, Professor John Iredell and Dr Muhammad Kamruzzaman from Plasmid Therapy are developing affordable probiotic-based oral therapies to restore antibiotic effectiveness, combat antibiotic resistance, and address a looming global health and economic crisis. A huge thank you to all the residents and Fast Start graduates who contributed to the success of this Showcase! 🎉 Interested in becoming a resident? 🧐 Cicada Innovations' HealthTech Hub provides exclusive access to a vibrant community of health tech innovators. Residents enjoy a range of benefits, from state-of-the-art facilities to access to commercialisation programs and networking connections. As well as gaining expert referral and partnership insights from leading healthcare and venture organisations, such as Brandon Capital. Learn more: https://lnkd.in/gNsyrYTf #DeepTech #Techinnovation #Biotech #startups #innovation #incubator